A randomized double-blind controlled proof-of-concept study of alanyl-glutamine for reduction of post-myomectomy adhesions
European Journal of Obstetrics & Gynecology and Reproductive Biology · 2023
DOI: 10.1016/j.ejogrb.2023.03.032 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Obstetrics & Gynecology and Reproductive Biology, 2023. Verfasst von Donna R Chizen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology, College of Medicine, University of Saskatchewan, SK, Canada. Hauptthemen laut MEDLINE: Uterine Myomectomy, Laparoscopy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
STUDY OBJECTIVE: To test the hypothesis that intraperitoneal instillation of a single bolus dose of l-alanyl-l-glutamine (AG) will reduce the incidence, extent and/or severity of adhesions following myomectomy and establish preliminary safety and tolerability of AG in humans. DESIGN: Phase 1,2 Randomized, double-blind, placebo-controlled study (DBRCT). SETTING: Tertiary care gynecology surgical centre. PATIENTS: Thirty-eight women who underwent myomectomies by laparoscopy (N = 38; AG-19 vs Placebo-19) or laparotomy (N = 10; AG-5 vs Placebo-5) with a scheduled second-look laparoscopy (SLL) 6-8 weeks later. Thirty-two patients in the laparoscopy arm completed SLL. INTERVENTIONS: Bolus dose of AG or normal saline solution control (0.9% NaCl) administered intraperitoneally immediately prior to suture closure of the laparoscopic ports. The average dose was 170 mL of AG or control based on a dosing scheme of 1 g/kg bodyweight. MEASUREMENTS: Digital recordings obtained for all procedures. The primary endpoint was reduction in the incidence, severity and extent of post-operative adhesions analyzed by intention-to-treat (ITT) approach. Three independent, blinded reviewers evaluated all operative video recordings to assess presence of adhesions. Post-hoc analysis assessed presence or absence of adhesions in the peritoneal cavity. Secondary endpoints assessed safety and tolerability of AG. MAIN RESULTS: Administration of AG reduced the incidence, severity and/or extent of post-operative adhesions (p = 0.046). The presence of adhesions in the AG group was lower than in the Control group (p = 0.041). Adhesion improvement was achieved in 15 of 15 (100%) in the AG group versus 5 of 17 (29.6%) in the placebo group. No serious adverse events were reported. No differences in safety parameters were observed. CONCLUSIONS: Intraperitoneal l-alanyl-l-glutamine reduced adhesion formation in all patients following laparoscopic myomectomy. Complete absence of adhesions was achieved at all abdominal sites in 93% of patients. Results confirm AG's known effects on cellular mechanisms of adhesiogenesis and lay the foundation for new adhesion prophylaxis research and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetrics and Gynecology, College of Medicine, University of Saskatchewan, SK, Canada.
- Faculty of Nursing, University of Regina, Saskatoon, SK, Canada.
- Temple Therapeutics B.V., Geleen, the Netherlands.
- Community Health and Epidemiology, College of Medicine, University of Saskatchewan, SK, Canada.
- Obstetrics and Gynecology, McGill University, Montreal, QC, Canada.
- Obstetrics, Gynecology and Reproductive Biology, Division of Reproductive Endocrinology and Infertility, Brigham and Women's Hospital and Harvard Medical School, MA, USA.
Zitieren
APA
Chizen, D. R., Rislund, D. C., Robertson, L. M., Lim, H. J., Tulandi, T., Gargiulo, A. R., De Wilde, R. L., Velygodskiy, A., & Pierson, R. A. (2023). A randomized double-blind controlled proof-of-concept study of alanyl-glutamine for reduction of post-myomectomy adhesions. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2023.03.032
Vancouver
Chizen DR, Rislund DC, Robertson LM, Lim HJ, Tulandi T, Gargiulo AR, et al. A randomized double-blind controlled proof-of-concept study of alanyl-glutamine for reduction of post-myomectomy adhesions. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2023. doi:10.1016/j.ejogrb.2023.03.032
BibTeX
@article{Chizen2023,
author = {Chizen, Donna R and Rislund, Dominique C and Robertson, Lynne M and Lim, Hyun J and Tulandi, Togas and Gargiulo, Antonio R and De Wilde, Rudy Leon and Velygodskiy, Aleksey and Pierson, Roger A},
title = {A randomized double-blind controlled proof-of-concept study of alanyl-glutamine for reduction of post-myomectomy adhesions},
journal = {European Journal of Obstetrics & Gynecology and Reproductive Biology},
year = {2023},
doi = {10.1016/j.ejogrb.2023.03.032}
}
EUVIMED